Sign In
Buy NTRA
$234.76
+5.96 (+2.60%)
At Close: Jun 23, 2026
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
Prospera™ Receives Positive Medicare Coverage
06:40pm, Monday, 11'th May 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that Noridian, a Medicare Administrative Contractor (MAC), has issued positive coverage for the Prosp
Natera, Inc. (NTRA) CEO Steve Chapman on Q1 2020 Results - Earnings Call Transcript
03:57am, Saturday, 09'th May 2020
Natera, Inc. (NASDAQ:NTRA) Q1 2020 Earnings Conference Call May 6, 2020 4:30 P.M. ET Company Participants Michael Brophy - Chief Financial Officer Steve Chapman
7 “Strong Buy” Healthcare Stocks to Buy Now
03:46pm, Friday, 08'th May 2020
As the month of May kicked off, stocks got off to a rocky start. The market slumped in response to a first quarter profit miss from eCommerce giant Amazon (NASDAQ:AMZN) and its plan to put all second-
Natera (NTRA) Q1 2020 Earnings Call Transcript
11:32am, Friday, 08'th May 2020
Ladies and gentlemen, thank you for joining us for the Natera, Inc. first-quarter 2020 earnings conference call. Also on the line is Steve Chapman, our CEO; Bob Schueren, chief operating officer; Sol
The Daily Biotech Pulse: Ayala IPO, Pluristem Starts Phase 2 Trial Of COVID Treatment, European Nod For Takeda
12:00am, Friday, 08'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 7)
• Acceleron Pharma Inc (...
Edited Transcript of NTRA earnings conference call or presentation 6-May-20 8:30pm GMT
11:09pm, Thursday, 07'th May 2020
Q1 2020 Natera Inc Earnings Call
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
U.S. RESEARCH ROUNDUP-Ashland Global Holdings, Lyft, Solaredge Technologies
07:34am, Thursday, 07'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge
Technologies, on Thursday.
HIG
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates
11:25pm, Wednesday, 06'th May 2020
Natera (NTRA) delivered earnings and revenue surprises of 21.05% and 4.96%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Natera Reports First Quarter 2020 Financial Results
08:05pm, Wednesday, 06'th May 2020
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today reported financial results for the first quarter ended March 31, 2020 and provided an update on recent business
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Is a Surprise Coming for Natera (NTRA) This Earnings Season?
02:35pm, Tuesday, 05'th May 2020
Natera (NTRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors o
